UK markets open in 58 minutes
NIKKEI 225
38,366.75 +814.59 (+2.17%) HANG SENG
17,179.52 +350.59 (+2.08%) CRUDE OIL
83.54 +0.18 (+0.22%) GOLD FUTURES
2,342.10 0.00 (0.00%) DOW
38,503.69 +263.71 (+0.69%) Bitcoin GBP
53,598.38 +169.65 (+0.32%)
Unity Biotechnology, Inc. (UBX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 24.96M |
| Enterprise value | 8.75M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 6.54 |
| Price/book (mrq) | 0.88 |
| Enterprise value/revenue | 29.79 |
| Enterprise value/EBITDA | -0.24 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.87 |
| 52-week change 3 | -28.37% |
| S&P500 52-week change 3 | 25.01% |
| 52-week high 3 | 3.8200 |
| 52-week low 3 | 1.4700 |
| 50-day moving average 3 | 1.6370 |
| 200-day moving average 3 | 2.0229 |
Share statistics
| Avg vol (3-month) 3 | 90.21k |
| Avg vol (10-day) 3 | 57.53k |
| Shares outstanding 5 | 16.79M |
| Implied shares outstanding 6 | 16.79M |
| Float 8 | 14.51M |
| % held by insiders 1 | 1.25% |
| % held by institutions 1 | 28.33% |
| Shares short (28 Mar 2024) 4 | 307.18k |
| Short ratio (28 Mar 2024) 4 | 2.18 |
| Short % of float (28 Mar 2024) 4 | 1.85% |
| Short % of shares outstanding (28 Mar 2024) 4 | 1.83% |
| Shares short (prior month 29 Feb 2024) 4 | 290.64k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:10 |
| Last split date 3 | 20 Oct 2022 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -25.30% |
| Return on equity (ttm) | -94.36% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -37.28M |
| Net income avi to common (ttm) | -39.86M |
| Diluted EPS (ttm) | -2.7000 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 43.2M |
| Total cash per share (mrq) | 2.57 |
| Total debt (mrq) | 26.99M |
| Total debt/equity (mrq) | 95.04% |
| Current ratio (mrq) | 5.95 |
| Book value per share (mrq) | 1.69 |
Cash flow statement
| Operating cash flow (ttm) | -37.09M |
| Levered free cash flow (ttm) | -20.6M |
© 2024 Yahoo. All rights reserved.